Cargando…

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?

BACKGROUND: The idea that the impact of opioid agonist treatment is influenced by the psychopathological profile of heroin addicts has not yet been investigated, and is based on the concept of a specific therapeutic action displayed by opioid agents on psychopathological symptoms. In the present rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maremmani, Angelo Giovanni Icro, Rovai, Luca, Pani, Pier Paolo, Pacini, Matteo, Lamanna, Francesco, Rugani, Fabio, Schiavi, Elisa, Dell'Osso, Liliana, Maremmani, Icro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113325/ https://www.ncbi.nlm.nih.gov/pubmed/21569624 http://dx.doi.org/10.1186/1744-859X-10-17

Ejemplares similares

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

Correlations Between Awareness of Illness (Insight) and History of Addiction in Heroin-Addicted Patients
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2012)

Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90)
por: Maremmani, Icro, et al.
Publicado: (2010)

Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
por: Pani, Pier Paolo, et al.
Publicado: (2014)

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?
por: Maremmani, Icro, et al.
Publicado: (2007)

Long-Term γ-Hydroxybutyric Acid (GHB) and Disulfiram Combination Therapy in GHB Treatment-Resistant Chronic Alcoholics
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode
por: Rugani, Fabio, et al.
Publicado: (2012)

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients
por: Maremmani, Angelo G.I., et al.
Publicado: (2019)

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2014)

Toward the Identification of a Specific Psychopathology of Substance Use Disorders
por: Maremmani, Angelo G. I., et al.
Publicado: (2017)

Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?
por: Pani, Pier Paolo, et al.
Publicado: (2016)

Further Evidence of a Specific Psychopathology of Addiction. Differentiation from Other Psychiatric Psychopathological Dimensions (Such as Obesity)
por: Maremmani, Angelo G.I., et al.
Publicado: (2017)

The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2016)

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
por: Della Rocca, Filippo, et al.
Publicado: (2023)

The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment
por: Maremmani, Angelo G. I., et al.
Publicado: (2016)

Delineating the Psychic Structure of Substance Use and Addictions, from Neurobiology to Clinical Implications: Ten Years Later
por: Pani, Pier Paolo, et al.
Publicado: (2020)

The Conceptual Framework of Dual Disorders and Its Flaws
por: Pacini, Matteo, et al.
Publicado: (2020)

Erratum to: Agonist Opioid Treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2017)

Tobacco Addiction and Smoking Status in Heroin Addicts under Methadone vs. Buprenorphine Therapy
por: Pajusco, Benedetta, et al.
Publicado: (2012)

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
por: Maremmani, Icro, et al.
Publicado: (2023)

Psychiatric Aspects of Obesity: A Narrative Review of Pathophysiology and Psychopathology
por: Weiss, Francesco, et al.
Publicado: (2020)

Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder
por: Maremmani, Icro, et al.
Publicado: (2015)

Adult separation anxiety in patients with complicated grief versus healthy control subjects: relationships with lifetime depressive and hypomanic symptoms
por: Dell'Osso, Liliana, et al.
Publicado: (2011)

Gender Differences in the Relationship between Maladaptive Behaviors and Post-Traumatic Stress Disorder. A Study on 900 L’ Aquila 2009 Earthquake Survivors
por: Dell’Osso, Liliana, et al.
Publicado: (2013)

Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health
por: Lovrecic, Barbara, et al.
Publicado: (2019)

Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood
por: Leventelis, Christonikos, et al.
Publicado: (2019)

Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome
por: Quaranta, Giuseppe, et al.
Publicado: (2015)

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
por: Manni, Corrado, et al.
Publicado: (2019)

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
por: Maremmani, Angelo G. I., et al.
Publicado: (2021)

Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model
por: Cenci, Davide, et al.
Publicado: (2022)

Toward an Individual Approach to Methadone Therapy of Heroin Addicts
Publicado: (2006)

Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features
por: Spera, Vincenza, et al.
Publicado: (2020)

Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?
por: Spera, Vincenza, et al.
Publicado: (2021)

Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review
por: Caputo, Fabio, et al.
Publicado: (2009)

Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pmqqqno5curfk304ovgc4mq3c8